When are assets complementary? Star scientists, strategic alliances, and innovation in the pharmaceutical industry

Strategic Management Journal

Volumn 32, Issue 8, 2011, Pages 895-909

  Hess, Andrew M ^a   Rothaermel, Frank T ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

complementary assets; innovation; pharmaceutical industry; star scientists; strategic alliances

Indexed keywords

COMPLEMENTARY ASSETS; INNOVATIVE PERFORMANCE; PHARMACEUTICAL FIRMS; PHARMACEUTICAL INDUSTRY; STRATEGIC ALLIANCE; VALUE CHAINS;

INDUSTRY;

STARS;

EID: 79958804722     PISSN: 01432095     EISSN: 10970266     Source Type: Journal    
DOI: 10.1002/smj.916     Document Type: Article

References (75)

1. Albert MB, Avery D, Narin F, McAllister P,. 1991. Direct validation of citation counts as indicators of industrially important patents. Research Policy 20 (3): 251-259.
2. Allen T, Cohen SI,. 1969. Information flow in R&D laboratories. Administrative Science Quarterly 14: 12-19.
3. Arora A, Ceccagnoli M,. 2006. Patent protection, complementary assets, and firms' incentives for technology licensing. Management Science 52 (2): 293-318.
4. Arora A, Gambardella A,. 1990. Complementarity and external linkages: the strategies of the large firms in biotechnology. Journal of Industrial Economics 38: 361-379.
5. Baum JAC, Calabrese T, Silverman BS,. 2000. Don't go it alone: alliance network composition and startups' performance in Canadian biotechnology. Strategic Management Journal, March Special Issue 21: 267-294.
6. Brown JS, Duguid P,. 2001. Knowledge and organization: a social-practice perspective. Organization Science 12 (2): 198-213.
7. Burnes T, Stalker G,. 1961. The Management of Innovation. Tavistock: London, UK.
8. Cameron AC, Trivedi PK,. 1986. Econometric models based on count data: comparisons and applications of some estimators and tests. Journal of Applied Econometrics 1 (1): 29-53.
9. Cassiman B, Veugelers R,. 2006. In search of complementarity in innovation strategy: internal R&D and external knowledge acquisition. Management Science 52 (1): 68-82.
10. Chesbrough HW,. 2003. Open Innovation: The New Imperative for Creating and Profiting from Technology Harvard Business School Press: Boston, MA.
11. Cockburn IM, Henderson RM,. 2001. Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research. Journal of Health Economics 20 (6): 1033-1057. (Pubitemid 33010787)
12. Cohen J, Cohen P, West SG, Aiken LS,. 2003. Applied Multiple Regression Correlation Analysis for the Behavioral Sciences (3rd edn). Erlbaum: Mahwah, NJ.
13. Cohen SN, Chang ACY, Boyer HW, Helling RB,. 1973. Construction of biologically functional bacterial plasmids in vitro. Proceedings of the National Academy of Sciences 70 (11): 3240-3244.
14. Cohen WM, Levinthal DA,. 1990. Absorptive capacity: a new perspective on learning and innovation. Administrative Science Quarterly 35: 128-152.
15. Dierickx I, Cool K,. 1989. Asset stock accumulation and sustainability of competitive advantage. Management Science 35 (12): 1504-1513.
16. Ettlie JE, Pavlou PA,. 2006. Technology-based new product development partnerships. Decision Sciences 37 (2): 117-147. (Pubitemid 44099934)
17. Furukawa R, Goto A,. 2006. The role of corporate scientists in innovation. Research Policy 35 (1): 24-36. (Pubitemid 43184057)
18. Galambos L, Sturchio J,. 1998. Pharmaceutical firms and the transition to biotechnology: a study in strategic innovation. Business History Review 72: 250-278.
19. Gambardella A,. 1992. Competitive advantage from in-house scientific research: the US pharmaceutical industry in the 1980s. Research Policy 21 (5): 391-407.
20. Gardner T,. 2005. Interfirm competition for human resources: evidence from the software industry. Academy of Management Journal 48 (2): 237-256. (Pubitemid 40747068)
21. Giovannetti G, Morrison S,. 2000. Convergence: The biotechnology Industry Report. Ernst & Young: Palo Alto, CA.
22. Grant R, Baden-Fuller C,. 2004. A knowledge accessing theory of strategic alliances. Journal of Management Studies 41 (1): 61-84. (Pubitemid 38201811)
23. Greene WH,. 2003. Econometric Analysis. Prentice Hall: Upper Saddle River, NJ.
24. Griliches Z, Pakes A, Hall BH,. 1987. The value of patents as indicators of inventive activity. In Economic Policy and Technological Performance, Dasgupta P, Stoneman P, (eds). Cambridge University Press: Cambridge, UK: 97-124.
25. Groysberg B, Lee L, Nanda A,. 2008. Can they take it with them? The portability of star knowledge workers' performance. Management Science 54 (7): 1213-1230.
26. Gulati R,. 1995. Does familiarity breed trust? The implications of repeated ties for contractual choice in alliances Academy of Management Journal 38: 85-112.
27. Gulati R,. 1998. Alliances and networks. Strategic Management Journal, April Special Issue 19: 293-317.
28. Gulati R,. 1999. Network location and learning: the influence of network resources and firm capabilities on alliance formation. Strategic Management Journal 20 (5): 397-420. (Pubitemid 129548660)
29. Hagedoorn J,. 1993. Understanding the rationale of strategic technology partnering: interorganizational modes of cooperation and sectoral differences. Strategic Management Journal 14 (95): 371-385.
30. Hall BH, Griliches Z, Hausman JA,. 1986. Patents and R&D: is there a lag? International Economic Review 27 (2): 265-283.
31. Hall BH, Jaffe A, Trajtenberg M,. 2001. The NBER patent citations data file: lessons, insights, and methodological tools. Working paper no. 8498. National Bureau of Economic Research: Cambridge, MA.
32. Hall BH, Jaffe A, Trajtenberg M,. 2005. Market value and patent citations. RAND Journal of Economics 36 (1): 16-38. (Pubitemid 40937906)
33. Hamilton BH, Nickerson JA,. 2003. Correcting for endogeneity in strategic management research. Strategic Organization 1 (1): 51-78.
34. Harrigan K,. 1986. Matching vertical integration strategies to competitive conditions. Strategic Management Journal 7 (6): 535-555.
35. Hausman JA,. 1978. Specification tests in econometrics. Econometrica 46 (6): 1251-1271.
36. Hausman J, Hall BH, Griliches Z,. 1984. Econometric models for count data with an application to the patents-R&D relationship. Econometrica 52 (4): 909-938.
37. Helfat CE,. 1994a. Evolutionary trajectories in petroleum firm R&D. Management Science 40 (12): 1720-1747.
38. Helfat CE,. 1994b. Firm specificity in corporate applied R&D. Organization Science 5: 173-173.
39. Helfat CE,. 1997. Know-how and asset complementarity and dynamic capability accumulation: the case of R&D. Strategic Management Journal 18 (5): 339-360. (Pubitemid 127467821)
40. Helfat CE, Peteraf MA,. 2003. The dynamic resource-based view: capability lifecycles. Strategic Management Journal, October Special Issue 24: 997-1010.
41. Helfat CE, Raubitschek RS,. 2000. Product sequencing: co-evolution of knowledge, capabilities and products. Strategic Management Journal, October-November Special Issue 21: 961-979.
42. Henderson RM, Cockburn IM,. 1994. Measuring competence? Exploring firm effects in pharmaceutical research. Strategic Management Journal, Winter Special Issue 15: 63-84.
43. IMS-Health. 2008. Global Pharmaceutical Sales 2000-2007. Available at: (15 September 2008).
44. Kogut B, Zander U,. 1992. Knowledge of the firm, combinative capabilities and the replication of technology. Organization Science 3 (3): 383-397.
45. Koza MP, Lewin AY,. 1998. The co-evolution of strategic alliances. Organization Science 9 (3): 255-264.
46. Lacetera N, Cockburn IM, Henderson RM,. 2004. Do firms change capabilities by hiring new people? A study of the adoption of science-based drug discovery. In Business Strategy over the Industry Lifecycle: Advances in Strategic Management, Baum JAC, McGahan AM, (eds). Elsevier: Oxford, UK; 133-159. (Pubitemid 39753019)
47. Lane PJ, Lubatkin MH,. 1998. Relative absorptive capacity and interorganizational learning. Strategic Management Journal 19 (5): 461-477. (Pubitemid 128468556)
48. Lavie D, Rosenkopf L,. 2006. Balancing exploration and exploitation in alliance formation. Academy of Management Journal 49 (6): 797-818. (Pubitemid 44453120)
49. Levinthal DA, March JG,. 1993. The myopia of learning. Strategic Management Journal, Winter Special Issue 14: 95-112.
50. Madhavan R, Grover R,. 1998. From embedded knowledge to embodied knowledge: new product development as knowledge management. Journal of Marketing 62 (4): 1-12.
51. March JG,. 1991. Exploration and exploitation in organizational learning. Organization Science 2 (1): 71-87.
52. Milgrom P, Roberts J,. 1995. Complementarities and fit strategy, structure, and organizational change in manufacturing. Journal of Accounting and Economics 19 (2-3): 179-208.
53. Murray F,. 2002. Innovation as co-evolution of scientific and technological networks: exploring tissue engineering. Research Policy 31: 1389-1403.
54. Park SH, Chen R, Gallagher S,. 2002. Firm resources as moderators of the relationship between market growth and strategic alliances in semiconductor start-ups. Academy of Management Journal 45 (3): 527-545.
55. Parmigiani A,. 2007. Why do firms both make and buy? An investigation of concurrent sourcing. Strategic Management Journal 28 (3): 285-311.
56. Parmigiani A, Mitchell W,. 2009. Complementarity, capabilities, and the boundaries of the firm: the impact of within-firm and interfirm expertise on concurrent sourcing of complementary components. Strategic Management Journal 30 (10): 1065-1091.
57. Peteraf MA,. 1993. The cornerstones of competitive advantage: a resource-based view. Strategic Management Journal 14 (3): 179-191.
58. Pisano G, Mang P,. 1993. Collaborative product development and the market for know-how: strategies and structures in the biotechnology industry. In Research on Technological Innovation, Management and Policy., Rosenbloom R, Burgelman R, (eds). JAI. Press: Greenwich, CT; 109-136.
59. Powell WW, Koput KW, Smith-Doerr L,. 1996. Interorganizational collaboration and the locus of innovation: networks of learning in biotechnology. Administrative Science Quarterly 41 (1): 116-145.
60. Reed R, DeFillippi RJ,. 1990. Causal ambiguity, barriers to imitation, and sustainable competitive advantage. Academy of Management Review 15: 88-102.
61. Rothaermel FT,. 2001. Incumbent's advantage through exploiting complementary assets via interfirm cooperation. Strategic Management Journal, June-July Special Issue 22: 687-699. (Pubitemid 33612464)
62. Rothaermel FT, Deeds DL,. 2004. Exploration and exploitation alliances in biotechnology: a system of new product development Strategic Management Journal 25 (3): 201-221.
63. Rothaermel FT, Hess AM,. 2007. Building dynamic capabilities: innovation driven by individual, firm, and network level effects. Organization Science 18 (6): 898-921.
64. Rothaermel FT, Hitt MA, Jobe LA,. 2006. Balancing vertical integration and strategic outsourcing: effects on product portfolio, product success, and firm performance. Strategic Management Journal 27 (11): 1033-1056. (Pubitemid 44580112)
65. Shan W, Walker G, Kogut B,. 1994. Interfirm cooperation and startup innovation in the biotechnology industry. Strategic Management Journal 15 (5): 387-394.
66. Shaver J,. 2007. Interpreting empirical results in strategy and management research. Research Methodology in Strategy and Management 4: 273-293.
67. Stephan P,. 1996. The economics of science. Journal of Economic Literature 34 (3): 1199-1235. (Pubitemid 126420567)
68. Stuart T,. 1998. Network positions and propensities to collaborate: an investigation of strategic alliance formation in a high-technology industry. Administrative Science Quarterly 43 (3): 668-698.
69. Teece DJ,. 1986. Profiting from technological innovation: implications for integration, collaboration, licensing and public policy. Research Policy 15 (6): 285-305.
70. Teece D,. 1992. Competition, cooperation, and innovation: organizational arrangements for regimes of rapid technological progress. Journal of Economic Behavior and Organization 18 (1): 1-25.
71. Tushman M, O'Reilly CA,. 1996. Ambidextrous organizations: managing evolutionary and revolutionary change. California Management Review 38 (4): 8-30.
72. Williamson O,. 1991. Comparative economic organization: the analysis of discrete structural alternatives. Administrative Science Quarterly 36 (2): 269-296.
73. Zucker LG, Darby MR,. 1996. Costly information: firm transformation, exit, or persistent failure. American Behavioral Scientist 39 (8): 959-974.
74. Zucker LG, Darby MR,. 1997. Individual action and the demand for institutions: star scientists and institutional transformation. American Behavioral Scientist 40 (4): 502-513.
75. Zucker LG, Darby MR, Brewer MB,. 1998. Intellectual human capital and the birth of U.S. biotechnology enterprises. American Economic Review 88 (1): 290-306. (Pubitemid 128452341)